Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$20.02
-1.09-5.16%
Last update: Oct 13, 8:09 AM
GH Research PLC (GHRS) Stock Price, Quote, News & History
GHRSNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of GH Research (NASDAQ:GHRS) through any online brokerage.
Other companies in GH Research’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
GH Research has a consensus price target of $40.50.
The stock price for GH Research (NASDAQ: GHRS) is $20 last updated October 13, 2026 at 8:09 AM EDT.
There are no upcoming dividends for GH Research.
GH Research does not have any upcoming earnings scheduled.
There is no upcoming split for GH Research.
GH Research is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
